Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Stoxx Europe 600 ESG UCITS ETF Acc

AME6 · LU1681040223 · class UCITS ETF Acc · EUR · domicile Luxembourg
Equity · Europe · Sustainable / ESGSFDR art. 8
Index tracked: STOXX Europe 600 ESG+
TER
0.18%+ trans. 0.13%
Fund size
1.9 bn EUR
Tracking difference
+0.21%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 17 Apr 2018 · costs from the KID as of 2 Sept 2026 · 489 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of STOXX Europe 600 ESG+ Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. The Sub-Fund promotes environmental and/or social…

Performance since series start (in euro) — base 100

18 Apr 20188 Sept 2026 · dividends reinvested where declared by the issuer
201920212023202521177207
High 211 (7 Aug 2026) · low 77 (18 Mar 2020) · last 207. Past performance is not indicative of future results.

Returns in euro

1 year+20.1%
3 years+51.4%
5 years+53.0%
10 yearsseries too young
Since series start+107.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.07%12.76%14.15%
Max drawdown−10.84%−16.14%−20.93%
Sharpe1.250.880.50
Sortino1.941.250.70
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · AME6 · LU16810402231
RebalixAME6 · LU1681040223 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+18.68%+18.47%+0.21%
2024+8.94%+8.75%+0.19%
2023+16.20%+15.97%+0.23%
2022−11.12%−11.12%+0.00%
2021+24.88%+24.91%−0.03%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 489 securities · top-10 weight = 22.9%
Top holdingsWeight
ASML HOLDING NV5.0%
HSBC HOLDINGS PLC2.7%
NOVARTIS AG-REG2.4%
ROCHE HOLDING AG - GENUSSS CHF2.3%
ASTRAZENECA GBP1.9%
NESTLE SA-REG1.9%
SIEMENS AG-REG1.8%
SAP SE / XETRA1.7%
BANCO SANTANDER SA MADRID1.7%
ALLIANZ SE-REG1.5%
Countries (% of fund)
United Kingdom19.6%Switzerland15.7%Germany14.4%France13.7%Netherlands9.2%
Sectors (% of fund)
Financials30.2%Industrials16.5%Health Care13.3%Information Technology9.9%Consumer Discretionary7.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
AME6 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
C6E · Euronext Paris
+ 25 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU1681040223/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU1681040223/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU1681040223/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU1681040223
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · AME6 · LU16810402232